Crossmark

ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients

Crossref DOI link: https://doi.org/10.1007/s13277-016-4802-y

Published Online: 2016-01-23

Published Print: 2016-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Almami, Amal

Hegazy, Samar A.

Nabbi, Arash

Alshalalfa, Mohammed

Salman, Asma

Abou-Ouf, Hatem

Riabowol, Karl

Bismar, Tarek A.
Funding

Funding for this research was provided by:

Prostate Cancer Canada (CA) (B2013-01)

Prostate Cancer Foundation (US) (NA)
License Information

Text and Data Mining valid from 2016-01-23